» Articles » PMID: 38392569

Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks

Overview
Journal J Pers Med
Date 2024 Feb 23
PMID 38392569
Authors
Affiliations
Soon will be listed here.
Abstract

Infertility is a condition defined by the failure to establish a clinical pregnancy after 12 months of regular, unprotected sexual intercourse or due to an impairment of a person's capacity to reproduce either as an individual or with their partner. The authors have set out to succinctly investigate, explore, and assess infertility treatments, harnessing the potential of stem cells to effectively and safely treat infertility; in addition, this paper will present the legal and regulatory complexities at the heart of stem cell research, with an overview of the legislative state of affairs in six major European countries. For couples who cannot benefit from assisted reproductive technologies (ART) to treat their infertility, stem-cells-based approaches have been shown to be a highly promising approach. Nonetheless, lingering ethical and immunological uncertainties require more conclusive findings and data before such treatment avenues can become mainstream and be applied on a large scale. The isolation of human embryonic stem cells (ESCs) is ethically controversial, since their collection involves the destruction of human embryonic tissue. Overall, stem cell research has resulted in important new breakthroughs in the treatment of infertility. The effort to untangle the complex web of ethical and legal issues associated with such therapeutic approaches will have to rely on evidence-based, broadly shared standards, guidelines, and best practices to make sure that the procreative rights of patients can be effectively reconciled with the core values at the heart of medical ethics.

Citing Articles

Decoding the Puzzle of Male Infertility: The Role of Infection, Inflammation, and Autoimmunity.

Sciorio R, De Paola L, Notari T, Ganduscio S, Amato P, Crifasi L Diagnostics (Basel). 2025; 15(5).

PMID: 40075794 PMC: 11899667. DOI: 10.3390/diagnostics15050547.


Endocannabinoid system upregulates the enrichment and differentiation of human iPSC- derived spermatogonial stem cells via CB2R agonism.

Gizer M, Onen S, Erol O, Aerts-Kaya F, Recber T, Nemutlu E Biol Res. 2025; 58(1):13.

PMID: 40069895 PMC: 11900634. DOI: 10.1186/s40659-025-00596-4.


COVID-19 and Female Fertility: An Observational Prospective Multicenter Cohort Study: Upholding Reproductive Rights in Emergency Circumstances.

Gullo G, Lopez A, Loreto C, Cucinella G, La Verde M, Andrisani A Diagnostics (Basel). 2024; 14(19).

PMID: 39410522 PMC: 11475084. DOI: 10.3390/diagnostics14192118.


Spermatozoon-propelled microcellular submarines combining innate magnetic hyperthermia with derived nanotherapies for thrombolysis and ischemia mitigation.

Weng P, Liu C, Jheng P, Chiang C, Chen Y, Rethi L J Nanobiotechnology. 2024; 22(1):470.

PMID: 39118029 PMC: 11308583. DOI: 10.1186/s12951-024-02716-w.

References
1.
Morrell K, Chavkin W . Conscientious objection to abortion and reproductive healthcare: a review of recent literature and implications for adolescents. Curr Opin Obstet Gynecol. 2015; 27(5):333-8. DOI: 10.1097/GCO.0000000000000196. View

2.
Murakami K, Hamazaki N, Hamada N, Nagamatsu G, Okamoto I, Ohta H . Generation of functional oocytes from male mice in vitro. Nature. 2023; 615(7954):900-906. DOI: 10.1038/s41586-023-05834-x. View

3.
Sun M, Wang S, Li Y, Yu L, Gu F, Wang C . Adipose-derived stem cells improved mouse ovary function after chemotherapy-induced ovary failure. Stem Cell Res Ther. 2013; 4(4):80. PMC: 3854877. DOI: 10.1186/scrt231. View

4.
Vaduva C, Constantinescu C, Radu M, Vaduva A, Panus A, tenovici M . Pregnancy resulting from IMSI after testicular biopsy in a patient with obstructive azoospermia. Rom J Morphol Embryol. 2016; 57(2 Suppl):879-883. View

5.
Lee Y, Kang E . Stem cells and reproduction. BMB Rep. 2019; 52(8):482-489. PMC: 6726211. View